Navigation Links
Savient Provides Update on Pegloticase BLA
Date:2/12/2009

ve in the relative benefit to risk profile of the safety and efficacy of this exciting product candidate when used in treating patients who suffer from treatment failure gout," said Paul Hamelin, President.

Key Amendments to the BLA

  • Clearer Data on Cardiovascular Profile. The results of the Company's independent post hoc both blinded and unblinded cardiovascular adjudication provided additional data, which clarified the previous understanding of the cardiovascular profiles of pegloticase. Further details of these findings are outlined below.

  • Updated Immunogenicity Guidance. With additional review and analyses, the Committee and its experts concluded that a clinically important immune response in pegloticase can be detected within the first 4 months through monitoring serum uric acid in normal medical practice patterns. A lack of uric acid response correlates with high levels of antibody production. The Company expects this to enable physicians to more quickly identify patients who should discontinue treatment.

  • Revised REMS Program. The Committee determined the Company's application would be strengthened by revising the Risk Evaluation and Mitigation Strategy (REMS) program. The revised REMS program proposed is based on an Elements To Assure Safe Use (ETASU) program. ETASU is a performance-linked access program for prescribers, infusion sites and patients that will have to enroll in this annual program and be certified in order to prescribe, administer or receive pegloticase. The Company also revised its previously proposed 1,000 patient observational study to be an expanded voluntary registry of up to 3,000 patients. The expanded registry will allow the Company to capture additional information about both the cardiovascular and immunogenicity profiles.

  • '/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. USAID Provides Malaria Assistance to Zimbabwe
3. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
4. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
5. American Dairy Provides Business Update
6. Alfacell Provides ONCONASE(R) NDA Submission Update
7. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
8. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
9. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
10. Raptor Pharmaceuticals Provides Update on Targeting Platforms
11. New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Sihuan Pharmaceutical ... the "Company"), a leading pharmaceutical company with the ... China,s prescription drug market, today ... and its subsidiaries (collectively the "Group") for the ... Financial HighlightsFor the Six months ended ...
(Date:8/27/2014)...  CVS Caremark (NYSE: CVS ) announced ... with MedStar Health, a leading health care system with ... the Washington, DC , region, which ... for patients. Through this clinical affiliation, MedStar Health patients ... counseling, chronic disease monitoring and wellness programs at CVS/pharmacy ...
(Date:8/27/2014)... , Aug. 27, 2014  UBM Medica US ... leading online community for medical imaging professionals, presents special ... for Medical Imaging Management,s 2014 Annual Meeting . ... coverage: , 11 Principles of Successful ... lead to greater profitability. , Why Don,t ...
Breaking Medicine Technology:Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3
(Date:8/28/2014)... VA (PRWEB) August 28, 2014 ... development, today announced that it has partnered with ... with the performance start date of 2/4/2014 with ... of Homeland Security (DHS) agency that oversees lawful ... contract, Coveros and InfoZen will automate the integration ...
(Date:8/28/2014)... 2014 On September 1st, the National ... campaign. The goal is to help families and ... and effectively and without exposures to risky pesticides. ... “Children’s exposures to pesticides should be limited as ... Head lice are often trivialized in the media, which ...
(Date:8/27/2014)... Asheville, NC (PRWEB) August 28, 2014 ... for companies to acquire as part of a ... business. Aeroflow is positioned for taking ownership of ... foundation to increase economies of scale. , Last ... an agreement with Hometown Respiratory to increase service ...
(Date:8/27/2014)... The report provides market analysis of ... Range Finder, LIDAR, 3D scanner, Laser Weapon, Dazzlers, Laser ... Laser Altimeter) by Domain (Aerospace, Defense and Homeland Security) ... by MarketsandMarkets, and its application in the aerospace and ... Laser Systems market is expected to register a CAGR ...
(Date:8/27/2014)... an innovative company that provides many kinds of top quality ... are now offered on its website. In addition, the firm ... that place an order for its newly released items can ... , The company’s senior spokesman was excited to talk ... and old customers can buy cheap bamboo panels on our ...
Breaking Medicine News(10 mins):Health News:Coveros Partners with InfoZen on USCIS Transformation Integration Award 2Health News:Head Lice Can Be a Public Health Opportunity 2Health News:Head Lice Can Be a Public Health Opportunity 3Health News:Head Lice Can Be a Public Health Opportunity 4Health News:Aeroflow Healthcare Seeks Strategic Acquisition Opportunities 2Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 4Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2
... its kind, have computed the rate of injury among competitive ... collegiate soccer or basketball// players. Led by researchers at Rhode ... study are published in the January 2007 issue of the ... competitive surfing has a relatively low risk of injury – ...
... the present guidelines should be modified affirms a recent ... Critical Care Medicine. This will need all foreign immigrants ... come from high risk areas around the world.This paper ... ,Data on all 2004 TB cases listed in the ...
... merely a figment of imagination. The feelings associated with it, ... be prevented or tackled// at the very onset, preventing it ... recent study shows that approximately 90 per cent of children ... miserable and homesick. This happens more often when children leave ...
... the winter cold and flu season//, a vocal health expert ... for preventing and treating the inflammation of the voice box. ... common cold and upper respiratory infection is something that is ... at some point in their life,” says Norman D. Hogikyan, ...
... are set to drastically lower the cost of medicines //and ... ,Sunil Shaunak, professor of infectious diseases at Imperial College, ... are leading clinical trials in India for a drug for ... way to invent new medicines and get them to market ...
... with normal lung function who later develop chronic cough ... chronic obstructive pulmonary disease (COPD). ,The results of ... for January 2007 of the American Journal of Respiratory ... Society. ,Isa Cerveri, M.D., of the Division ...
Cached Medicine News:Health News:Surfing Safer Than Soccer: Study 2Health News:Surfing Safer Than Soccer: Study 3Health News:TB can Be Eradicated in the U.S With Modified Guidelines: Study 2Health News:Coping With Homesickness 2Health News:Tips to Prevent and Treat Winter Laryngitis 2Health News:NRI Doctor's R&D Model in India to Slash Cost of Drugs 2Health News:Cough and Phlegm Cause Fourfold Increase in COPD Incidence 2
... Focus multichannel pipettes speed ... reagents into microplates, with ... l volumes. The improved ... Focus multichannels, combined with ...
... in a wide variety of applications. • Whole ... can be freely rotated against the handle to ... an optimum angle towards the microtiter plate. • ... of most common pipette tips, and provides a ...
Pipetman 8X200 Multichannel Pipette is an eight-channel, fully adjustable, air-displacement pipette having a useful volume range from 20 L to 200 L. Robustwith the usual Gilson qualities this pipette...
... 96-well plates in mind, Pipetman Ultra ... biology applications: PCR* sequencing, immunology assays, ... Used with Diamond Tips from Gilson's ... will maximize performance and assure productivity.,* ...
Medicine Products: